Skip Skippack COVID-19 Test, FDA Warns
Agency designates company recall class I
The Food and Drug Administration has designated the recall of a COVID-19 test from SML Distribution LLC as class I, the US agency’s most serious classification.
You may also be interested in...
A panel of industry experts gave the US FDA’s Digital Software Precertification Program the thumbs-up during a MedCon session.
Sub-standard supplemental oxygen devices that have flooded the market since the COVID-19 pandemic may pose a danger to patients with Chronic Obstructive Pulmonary Disease, a patient advocacy group says.
David Maman is the CEO and founder of Binah.ai, a provider of video-based health monitoring tools powered by artificial intelligence. Maman shared with Medtech Insight his thoughts on the FDA’s recent guidance to increase racial and ethnic diversity in clinical trials.